Cannabis as a Gateway Drug for Opioid Use Disorder.
J Law Med Ethics. 2020 Jun;48(2):268-274
Authors: Williams AR
Cannabis use in some individuals can meaningfully introduce de novo risk for the initiation of opioid use and development of opioid use disorder. These risks may be particularly high during adolescence when cannabis use may disrupt critical periods of neurodevelopment. Current research studying the combination of genetic and environmental factors involved in substance use disorders is poorly understood. More research is needed, particularly to identify which adolescents are most at risk and to develop effective interventions addressing contributing factors such as trauma and psychiatric comorbidity.
PMID: 32631185 [PubMed – in process]
Source: ncbi 2